Cargando…

Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH

BACKGROUND: Nonalcoholic steatohepatitis (NASH) is a chronic progression of nonalcoholic fatty liver disease, which can negatively impact the health-related quality of life (HRQoL) of affected individuals. HRQoL in NASH has been assessed using the disease-specific Chronic Liver Disease Questionnaire...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fishman, Jesse, Higgins, Victoria, Piercy, James, Pike, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576276/ https://www.ncbi.nlm.nih.gov/pubmed/37838660 http://dx.doi.org/10.1186/s12955-023-02195-x

Ejemplares similares

EQ-5D and the EuroQol Group: Past, Present and Future
por: Devlin, Nancy J., et al.
Publicado: (2017)

Quality of Life in Dyspepsia and its Subgroups Using EQ-5D (EuroQol) Questionnaire
por: Shetty, Anurag J., et al.
Publicado: (2017)

Reliability and validity of the Chronic Liver Disease Questionnaire (CLDQ) in adults with non-alcoholic steatohepatitis (NASH)
por: Chawla, Kashmira S, et al.
Publicado: (2016)

Validity and reliability of the Arabic version of the the EuroQOL (EQ-5D). A study from Saudi Arabia
por: Bekairy, Abdulkareem M., et al.
Publicado: (2018)

EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study
por: Hernandez, Gimena, et al.
Publicado: (2019)

Comparative performance of the EuroQol EQ-5D-5L and the CDC healthy days measures in assessing population health
por: Derkach, Maryna, et al.
Publicado: (2022)

Mapping of the Insomnia Severity Index and other sleep measures to EuroQol EQ-5D health state utilities
por: Gu, Ning Yan, et al.
Publicado: (2011)

The burden of nonalcoholic steatohepatitis (NASH) in the United States
por: Tapper, Elliot B., et al.
Publicado: (2023)

A Novel Animal Model of Nonalcoholic Steatohepatitis (NASH): Hypoxemia Enhances the Development of NASH
por: Takayama, Fusako, et al.
Publicado: (2009)

Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol
por: Hansen, Tonya Moen, et al.
Publicado: (2020)

Quality of Life Assessment Using EuroQOL EQ-5D Questionnaire in Patients with Deep Infiltrating Endometriosis: The Relation with Symptoms and Locations
por: Touboul, C., et al.
Publicado: (2013)

Nonalcoholic steatohepatitis (NASH) is associated with cardiac remodeling and dysfunction
por: Simon, Tracey G., et al.
Publicado: (2017)

Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH)
por: Qi, Xiaoyan, et al.
Publicado: (2022)

Measuring health-related quality of life of older people with frailty receiving acute care: feasibility and psychometric performance of the EuroQol EQ-5D
por: van Oppen, James D., et al.
Publicado: (2023)

Meta-analysis of health state utility values measured by EuroQol 5-dimensions (EQ5D) questionnaire in Chinese women with breast cancer
por: Rautenberg, Tamlyn, et al.
Publicado: (2022)

Estimation of EuroQol 5-Dimensions health status utility values in hereditary angioedema
por: Aygören-Pürsün, Emel, et al.
Publicado: (2016)

Responsiveness of the EuroQoL 5-Dimension (EQ-5D) questionnaire in patients with spondyloarthritis
por: Tsang, Helen Hoi Lun, et al.
Publicado: (2021)

Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort
por: Sidovar, Matthew F, et al.
Publicado: (2016)

Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain
por: Obradovic, Marko, et al.
Publicado: (2013)

Validity of the AusTOM scales: A comparison of the AusTOMs and EuroQol-5D
por: Unsworth, Carolyn A, et al.
Publicado: (2004)

Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma
por: Kutlu, Ozlem, et al.
Publicado: (2018)

A new method to induce nonalcoholic steatohepatitis (NASH) in mice
por: Savari, Feryal, et al.
Publicado: (2019)

Psychometric validation of the EuroQoL 5-dimension (EQ-5D) questionnaire in patients with spondyloarthritis
por: Tsang, Helen Hoi Lun, et al.
Publicado: (2019)

EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
por: Oppe, Mark, et al.
Publicado: (2016)

Health-Related Quality of Life (HRQoL) Outcomes Following Injury in Childhood and Adolescence Using EuroQol (EQ-5D) Responses with Pooled Longitudinal Data
por: Dipnall, Joanna F., et al.
Publicado: (2021)

Impact evaluation and association with EuroQol 5D health-related utility values in Ménière’s disease
por: Pyykkő, Ilmari, et al.
Publicado: (2015)

Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)
por: Yoneda, Masato, et al.
Publicado: (2008)

Population Pharmacokinetics of Morphine in Patients With Nonalcoholic Steatohepatitis (NASH) and Healthy Adults
por: Pierre, V, et al.
Publicado: (2017)

Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH)
por: Hartimath, S. V., et al.
Publicado: (2019)

Hepatic Molecular Signatures Highlight the Sexual Dimorphism of Nonalcoholic Steatohepatitis (NASH)
por: Vandel, Jimmy, et al.
Publicado: (2020)

The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression
por: Li, Xinzhi, et al.
Publicado: (2021)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019)

Mapping the 12-item multiple sclerosis walking scale to the EuroQol 5-dimension index measure in North American multiple sclerosis patients
por: Sidovar, Matthew F, et al.
Publicado: (2013)

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
por: Younossi, Zobair M., et al.
Publicado: (2023)

Soluble Endoglin as a Potential Biomarker of Nonalcoholic Steatohepatitis (NASH) Development, Participating in Aggravation of NASH-Related Changes in Mouse Liver
por: Igreja Sá, Ivone Cristina, et al.
Publicado: (2020)

EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates in HIV-infected adults under care
por: Mathews, William C, et al.
Publicado: (2007)

Disease profile and health-related quality of life (HRQoL) using the EuroQol (EQ-5D + C) questionnaire for chronic metallic mercury vapor intoxication
por: Steckling, Nadine, et al.
Publicado: (2015)

Measuring quality of life after intensive care using the Arabic version for Morocco of the EuroQol 5 Dimensions
por: Khoudri, Ibtissam, et al.
Publicado: (2012)

Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis
por: Twiss, James, et al.
Publicado: (2023)

Plasma levels of vitamin E and carotenoids are decreased in patients with nonalcoholic steatohepatitis (NASH)
por: Erhardt, A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_oq0ivp50e2vp7d0surgkunr11h